Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure With Reduced Ejection Fraction in a Safety-Net Health Care System
1 VA Palo Alto Health Care System, Palo Alto, CA; Division of Cardiology, Stanford University School of Medicine, Palo Alto, CA. Electronic address: cdejong@stanford.edu.
2 Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA.
3 Division of Pharmacy, Zuckerberg San Francisco General Hospital, San Francisco, San Francisco, CA.
4 Division of Cardiology, Washington University School of Medicine in St. Louis, St. Louis, MO.
5 Richard A. and Susan F. Smith Center for Outcomes Research, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA.
6 Division of HIV, Infectious Disease, and Global Medicine, University of California, San Francisco, San Francisco, CA.
7 Division of Prevention Science, Department of Medicine, University of California, San Francisco, CA.
8 Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA; Division of Clinical Informatics and Digital Transformation, University of California, San Francisco, San Francisco, CA.
9 Cardiovascular Division and Global Health Center, Washington University School of Medicine in St. Louis, St. Louis, MO; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
10 VA Palo Alto Health Care System, Palo Alto, CA; Division of Cardiology, Stanford University School of Medicine, Palo Alto, CA.
11 Cardiovascular Division and Global Health Center, Washington University School of Medicine in St. Louis, St. Louis, MO.
12 Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA.